GO
Loading...

BioMarin's CEO On Its Product Pipeline

Tuesday, 8 Jan 2013 | 2:20 PM ET

The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.